Showing results (411-420 of 433) with videos related to
Sort By:
Pageof 44
Journal of Medicinal Chemistry|September 10, 2021
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse EffectsSoumen Chakraborty, Jeffrey F DiBerto, Abdelfattah Faouzi, et al.Cell|February 6, 2018
5-HT2C Receptor Structures Reveal the Structural Basis of GPCR PolypharmacologyYao Peng, John D McCorvy, Kasper Harpsøe, et al.Nature|April 26, 2019
Structural basis of ligand recognition at the human MT1 melatonin receptorBenjamin Stauch, Linda C Johansson, John D McCorvy, et al.Frontiers in Pharmacology|April 9, 2021
COVID-19: Famotidine, Histamine, Mast Cells, and MechanismsRobert W Malone, Philip Tisdall, Philip Fremont-Smith, et al.Nature|November 30, 2022
Structure-based design of bitopic ligands for the µ-opioid receptorAbdelfattah Faouzi, Haoqing Wang, Saheem A Zaidi, et al.Science Advances|February 11, 2026
Structure-based design of an opioid receptor modulator for enhanced morphine analgesiaYue Wang, Ping Luo, Haiyan Xu, et al.Plos One|March 11, 2016
In Vitro and In Vivo Characterization of the Alkaloid NuciferineMartilias S Farrell, John D McCorvy, Xi-Ping Huang, et al.Nature|May 4, 2019
Publisher Correction: Structural basis of ligand recognition at the human MT1 melatonin receptorBenjamin Stauch, Linda C Johansson, John D McCorvy, et al.Angewandte Chemie (International Ed. in English)|March 3, 2015
A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3)H Ümit Kaniskan, Magdalena M Szewczyk, Zhengtian Yu, et al.Nature Neuroscience|July 8, 2020
Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeysYuji Nagai, Naohisa Miyakawa, Hiroyuki Takuwa, et al.Pageof 44